Cengild Medical Berhad (KLSE: CENGILD)

Market Cap	229.05M
Revenue (ttm)	66.85M
Net Income (ttm)	11.09M
Shares Out	832.91M
EPS (ttm)	0.01
PE Ratio	20.68
Forward PE	n/a
Dividend	0.01 (2.64%)
Ex-Dividend Date	Sep 10, 2024

Volume	85,900
Open	0.280
Previous Close	0.275
Day's Range	0.275 - 0.280
52-Week Range	0.270 - 0.395
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Cengild Medical Berhad

Cengild Medical Berhad, an investment holding company, engages in the operation of medical centers in Malaysia. The company provides various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; and general cardiology and gynecology assessment, gastroenterology, and hepatology, as well as gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery. It also provides medical management services, ...

• Industry: Health Services
• Founded: 2017
• Employees: 130
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: CENGILD

Financial Performance

In 2024, Cengild Medical Berhad's revenue was 66.85 million, a decrease of -4.87% compared to the previous year's 70.28 million. Earnings were 11.09 million, a decrease of -16.58%.